07 08 2015

JenaValve Receives $26.5 Million Financing
Proceeds to Enable Clinical Studies and Commercial Development of Innovative TAVR Systems Targeting Broad Patient Population

JenaValve Technology, Inc., a developer, manufacturer and marketer of next-generation transcatheter aortic valve repair (TAVR) systems for the treatment of aortic valve disease, today announced the successful completion of a $26.5 million Series C expansion round of financing. Proceeds from the financing will be used to support the Company’s...

LOGIN
To read the entire article, you must be a registered user.
Click here to register for free now, or fill out the form below to log in

Email:

Password:

Forgot password?

LATEST ISSUE
Powered by Share Trading

POPULAR ARTICLES
Technavio Says the Emergence of Green Fleet-management Solutions Will Propel the Fleet Management Market in Europe Through 2019

07/08/2015

Technavio, a tech-focused research firm, has published a new report on the fleet manage

Quad Group expands futures trading desk with key hires

07/08/2015

Quad Group, consisting of Quad Capital Management, Quad Securities Holdings and Quad Ad

The Quiet Financial Revolution Begins

07/08/2015

LAGUNA BEACH – Steadily and indisputably, the financial services industry –

Inequality, Immigration, and Hypocrisy

07/08/2015

CAMBRIDGE – Europe’s migration crisis exposes a fundamental flaw, if not to

Wall Street Horizon appoints Eric Soderberg as Chief Marketing Officer

07/08/2015

Wall Street Horizon, a provider of single-stock event research data for institutional i